Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank89
3Y CAGR+70.5%
5Y CAGR-2.8%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+70.5%/yr
vs +6.0%/yr prior
5Y CAGR
-2.8%/yr
Recent acceleration
Acceleration
+64.6pp
Accelerating
Percentile
P89
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 40.57% |
| Q2 2025 | 2.53% |
| Q1 2025 | -9.61% |
| Q4 2024 | -32.77% |
| Q3 2024 | 23.53% |
| Q2 2024 | -4.20% |
| Q1 2024 | 5.66% |
| Q4 2023 | 1.62% |
| Q3 2023 | -21.55% |
| Q2 2023 | 21.55% |
| Q1 2023 | -9.01% |
| Q4 2022 | -15.04% |
| Q3 2022 | 8.19% |
| Q2 2022 | -13.73% |
| Q1 2022 | -5.70% |
| Q4 2021 | 4.44% |
| Q3 2021 | -537.10% |
| Q2 2021 | 13.90% |
| Q1 2021 | 20.11% |
| Q4 2020 | 50.30% |
| Q3 2020 | 46.77% |
| Q2 2020 | -410.94% |
| Q1 2020 | 84.23% |
| Q4 2019 | 66.01% |
| Q3 2019 | -6.01% |
| Q2 2019 | 6.78% |
| Q1 2019 | 13.72% |
| Q4 2018 | -30.87% |
| Q3 2018 | 10.28% |
| Q2 2018 | 1.82% |
| Q1 2018 | -3.28% |
| Q4 2017 | -41.79% |
| Q3 2017 | -10.04% |
| Q2 2017 | -35.88% |
| Q1 2017 | 0.00% |
| Q4 2015 | -28.71% |
| Q3 2015 | -25.47% |
| Q2 2015 | -198.37% |
| Q1 2015 | 0.00% |